Cathie Wood Iovance Biotherapeutics, Inc. Transaction History

Ark Investment Management LLC

$11 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$5.36 - $9.06 $177,839 - $300,601	-33,179 Reduced 4.1%	775,787 $5.46 Million
Q1 2023 Apr 17, 2023	SELL	$5.53 - $8.22 $60,265 - $89,581	-10,898 Reduced 1.33%	808,966 $4.94 Million
Q4 2022 Jan 24, 2023	SELL	$5.62 - $10.0 $8.42 Million - $15 Million	-1,497,353 Reduced 64.62%	819,864 $0
Q3 2022 Oct 17, 2022	SELL	$9.53 - $13.11 $5.89 Million - $8.11 Million	-618,462 Reduced 21.07%	2,317,217 $22.2 Million
Q2 2022 Jul 11, 2022	SELL	$6.38 - $18.33 $649,254 - $1.87 Million	-101,764 Reduced 3.35%	2,935,679 $19.8 Million
Q1 2022 Apr 19, 2022	SELL	$12.38 - $19.1 $51.6 Million - $79.5 Million	-4,164,075 Reduced 57.82%	3,037,443 $50.6 Million
Q4 2021 Jan 28, 2022	SELL	$16.55 - $27.63 $73.6 Million - $123 Million	-4,448,319 Reduced 38.18%	7,201,518 $137 Million
Q3 2021 Nov 12, 2021	SELL	$20.35 - $26.63 $138 Million - $181 Million	-6,800,876 Reduced 36.86%	11,649,837 $287 Million
Q2 2021 Aug 05, 2021	SELL	$16.33 - $33.07 $20.8 Million - $42.2 Million	-1,275,937 Reduced 6.47%	18,450,713 $480 Million
Q1 2021 May 13, 2021	BUY	$28.67 - $52.59 $127 Million - $233 Million	4,428,828 Added 28.95%	19,726,650 $625 Million
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $207 Million - $372 Million	7,394,514 Added 93.56%	15,297,822 $710 Million
Q3 2020 Oct 30, 2020	BUY	$27.75 - $36.3 $102 Million - $133 Million	3,668,035 Added 86.61%	7,903,308 $260 Million
Q2 2020 Aug 11, 2020	BUY	$27.21 - $41.0 $91.1 Million - $137 Million	3,348,094 Added 377.39%	4,235,273 $116 Million
Q1 2020 May 14, 2020	BUY	$19.54 - $38.85 $1.25 Million - $2.48 Million	63,835 Added 7.75%	887,179 $26.6 Million
Q4 2019 Jan 31, 2020	BUY	$17.95 - $29.41 $153,436 - $251,396	8,548 Added 1.05%	823,344 $22.8 Million
Q3 2019 Nov 12, 2019	BUY	$17.99 - $26.0 $127,872 - $184,808	7,108 Added 0.88%	814,796 $14.8 Million
Q2 2019 Jul 30, 2019	BUY	$9.78 - $24.52 $1.14 Million - $2.85 Million	116,194 Added 16.8%	807,688 $19.8 Million
Q1 2019 May 13, 2019	SELL	$8.41 - $11.26 $293,223 - $392,591	-34,866 Reduced 4.8%	691,494 $6.58 Million
Q4 2018 Feb 01, 2019	BUY	$7.51 - $11.93 $2.26 Million - $3.6 Million	301,540 Added 70.98%	726,360 $6.43 Million
Q3 2018 Nov 07, 2018	BUY	$11.25 - $17.7 $3.4 Million - $5.35 Million	302,197 Added 246.44%	424,820 $4.78 Million
Q2 2018 Aug 07, 2018	BUY	$12.45 - $16.95 $716,211 - $975,082	57,527 Added 88.37%	122,623 $1.57 Million
Q1 2018 May 14, 2018	BUY	$8.1 - $19.5 $527,277 - $1.27 Million	65,096 New	65,096 $1.1 Million

Others Institutions Holding IOVA

# of Institutions

319

Shares Held

238M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account